Safety and efficacy of single-agent bevacizumab-containing therapy in elderly patients with platinum-resistant recurrent ovarian cancer: Subgroup analysis of the randomised phase III AURELIA trial
Roberto Sorio(Centro di Riferimento Oncologico), C. Roemer-Bécuwe, Felix Hilpert(Krankenhaus Jerusalem), Emma Gibbs(University of Sydney), Yolanda García García(Corporació Sanitària Parc Taulí), J. Kærn(Oslo University Hospital), Manon Huizing(Antwerp University Hospital), Petronella O. Witteveen(University Medical Center Utrecht), Flora Zagouri(Hellenic Cooperative Oncology Group), David Coeffic(L’Institut du Cancer Courlancy Reims), H.-J. Lück, Antonio González-Martı́n(MD Anderson Cancer Center Madrid), Gunnar B. Kristensen(Norwegian Cancer Society), Charles-Briac Levaché, Chee Khoon Lee(National Health and Medical Research Council), Val Gebski(University of Sydney), Éric Pujade-Lauraine(Assistance Publique – Hôpitaux de Paris)
Cited by 27
Abstract
Related Papers
No related papers found
Powered by citation graph analysis